Stay updated on MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial
Sign up to get notified when there's something new on the MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial page.

Latest updates to the MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedCore content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.SummaryDifference11%
- Check21 days agoChange DetectedUpdates the page version from v3.0.2 to v3.1.0, updating the core metadata/document revision tag.SummaryDifference0.3%
- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedUpdated the page from v3.0.1 to v3.0.2 and removed the Back to Top element.SummaryDifference0.6%
- Check43 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.6%
- Check50 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information. This suggests a shift towards a more generalized presentation of location data.SummaryDifference29%
- Check64 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
Stay in the know with updates to MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial page.